352 related articles for article (PubMed ID: 25572030)
1. NSAID enteropathy and bacteria: a complicated relationship.
Syer SD; Blackler RW; Martin R; de Palma G; Rossi L; Verdu E; Bercik P; Surette MG; Aucouturier A; Langella P; Wallace JL
J Gastroenterol; 2015 Apr; 50(4):387-93. PubMed ID: 25572030
[TBL] [Abstract][Full Text] [Related]
2. Microbiota Plays a Key Role in Non-Steroidal Anti-Inflammatory Drug-Induced Small Intestinal Damage.
Otani K; Tanigawa T; Watanabe T; Shimada S; Nadatani Y; Nagami Y; Tanaka F; Kamata N; Yamagami H; Shiba M; Tominaga K; Fujiwara Y; Arakawa T
Digestion; 2017; 95(1):22-28. PubMed ID: 28052268
[TBL] [Abstract][Full Text] [Related]
3. Psychological stress exacerbates NSAID-induced small bowel injury by inducing changes in intestinal microbiota and permeability via glucocorticoid receptor signaling.
Yoshikawa K; Kurihara C; Furuhashi H; Takajo T; Maruta K; Yasutake Y; Sato H; Narimatsu K; Okada Y; Higashiyama M; Watanabe C; Komoto S; Tomita K; Nagao S; Miura S; Tajiri H; Hokari R
J Gastroenterol; 2017 Jan; 52(1):61-71. PubMed ID: 27075753
[TBL] [Abstract][Full Text] [Related]
4. Gut Microbiota in NSAID Enteropathy: New Insights From Inside.
Wang X; Tang Q; Hou H; Zhang W; Li M; Chen D; Gu Y; Wang B; Hou J; Liu Y; Cao H
Front Cell Infect Microbiol; 2021; 11():679396. PubMed ID: 34295835
[TBL] [Abstract][Full Text] [Related]
5. Influence of Microbiota on NSAID Enteropathy: A Systematic Review of Current Knowledge and the Role of Probiotics.
Rekatsina M; Paladini A; Cifone MG; Lombardi F; Pergolizzi JV; Varrassi G
Adv Ther; 2020 May; 37(5):1933-1945. PubMed ID: 32291647
[TBL] [Abstract][Full Text] [Related]
6. NSAID gastropathy and enteropathy: distinct pathogenesis likely necessitates distinct prevention strategies.
Wallace JL
Br J Pharmacol; 2012 Jan; 165(1):67-74. PubMed ID: 21627632
[TBL] [Abstract][Full Text] [Related]
7. Management of NSAID/aspirin-induced small intestinal damage by GI-sparing NSAIDs, anti-ulcer drugs and food constituents.
Satoh H; Takeuchi K
Curr Med Chem; 2012; 19(1):82-9. PubMed ID: 22300080
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms, prevention and clinical implications of nonsteroidal anti-inflammatory drug-enteropathy.
Wallace JL
World J Gastroenterol; 2013 Mar; 19(12):1861-76. PubMed ID: 23569332
[TBL] [Abstract][Full Text] [Related]
9. FFA3 Activation Stimulates Duodenal Bicarbonate Secretion and Prevents NSAID-Induced Enteropathy via the GLP-2 Pathway in Rats.
Said H; Akiba Y; Narimatsu K; Maruta K; Kuri A; Iwamoto KI; Kuwahara A; Kaunitz JD
Dig Dis Sci; 2017 Aug; 62(8):1944-1952. PubMed ID: 28523577
[TBL] [Abstract][Full Text] [Related]
10. NSAID-induced small intestinal damage--roles of various pathogenic factors.
Takeuchi K; Satoh H
Digestion; 2015; 91(3):218-32. PubMed ID: 25791157
[TBL] [Abstract][Full Text] [Related]
11. NSAID enteropathy: could probiotics prevent it?
Montalto M; Gallo A; Gasbarrini A; Landolfi R
J Gastroenterol; 2013 Jun; 48(6):689-97. PubMed ID: 22875474
[TBL] [Abstract][Full Text] [Related]
12. Ciprofloxacin blocked enterohepatic circulation of diclofenac and alleviated NSAID-induced enteropathy in rats partly by inhibiting intestinal β-glucuronidase activity.
Zhong ZY; Sun BB; Shu N; Xie QS; Tang XG; Ling ZL; Wang F; Zhao KJ; Xu P; Zhang M; Li Y; Chen Y; Liu L; Xia LZ; Liu XD
Acta Pharmacol Sin; 2016 Jul; 37(7):1002-12. PubMed ID: 27180979
[TBL] [Abstract][Full Text] [Related]
13. Detection and prevention of NSAID-induced enteropathy.
Davies NM; Saleh JY; Skjodt NM
J Pharm Pharm Sci; 2000; 3(1):137-55. PubMed ID: 10954683
[TBL] [Abstract][Full Text] [Related]
14. Hydrogen sulphide protects against NSAID-enteropathy through modulation of bile and the microbiota.
Blackler RW; Motta JP; Manko A; Workentine M; Bercik P; Surette MG; Wallace JL
Br J Pharmacol; 2015 Feb; 172(4):992-1004. PubMed ID: 25297699
[TBL] [Abstract][Full Text] [Related]
15. Nonsteroidal anti-inflammatory drug-induced enteropathy: case discussion and review of the literature.
Kwo PY; Tremaine WJ
Mayo Clin Proc; 1995 Jan; 70(1):55-61. PubMed ID: 7808053
[TBL] [Abstract][Full Text] [Related]
16. NSAIDs and the small bowel.
Tai FWD; McAlindon ME
Curr Opin Gastroenterol; 2018 May; 34(3):175-182. PubMed ID: 29438118
[TBL] [Abstract][Full Text] [Related]
17. Pharmacologic targeting or genetic deletion of mitochondrial cyclophilin D protects from NSAID-induced small intestinal ulceration in mice.
LoGuidice A; Ramirez-Alcantara V; Proli A; Gavillet B; Boelsterli UA
Toxicol Sci; 2010 Nov; 118(1):276-85. PubMed ID: 20668000
[TBL] [Abstract][Full Text] [Related]
18. Prevention and management of non-steroidal anti-inflammatory drugs-induced small intestinal injury.
Park SC; Chun HJ; Kang CD; Sul D
World J Gastroenterol; 2011 Nov; 17(42):4647-53. PubMed ID: 22180706
[TBL] [Abstract][Full Text] [Related]
19. Non-specific multiple ulcers of the small intestine unrelated to non-steroidal anti-inflammatory drugs.
Matsumoto T; Iida M; Matsui T; Yao T; Watanabe H; Yao T; Okabe H
J Clin Pathol; 2004 Nov; 57(11):1145-50. PubMed ID: 15509673
[TBL] [Abstract][Full Text] [Related]
20. Microbial flora in NSAID-induced intestinal damage: a role for antibiotics?
Lanas A; Scarpignato C
Digestion; 2006; 73 Suppl 1():136-50. PubMed ID: 16498262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
